After 30 years of Gulf War Illness research, UTSW has identified the chemical – and a genetic variant – that made some servicemembers chronically ill while some had no symptoms.
After COVID-19 infection, many patients struggle with "brain fog" and muscle weakness. See how custom Physical Medicine & Rehabilitation care can improve patients' long-term health.
For decades, there were no FDA-approved treatments for cardiac amyloidosis in the U.S. But in the last two years, two new therapies were approved for cardiac- and nerve-related ATTR. In this week's MedBlog, Justin Grodin, M.D., discusses these therapies and what they mean for North Texas patients.
